2022 Vaccine Market Report
The U.S. vaccine market is expected to reach $30 billion by 2027, fueled by COVID-19 vaccines, development of new vaccine technologies, and advances in clinical research. The growth and approval of pediatric vaccinations and universal vaccine trials have also significantly contributed to the market expansion. The 2022 Vaccine Market Report describes the overall vaccine market, including the approval process, the impact of the COVID-19 pandemic, necessary vaccine supplies and market value for childhood, adult, influenza, and COVID-19 vaccines.
- 11.3 billion doses of COVID-19 vaccines were administered globally.
- An estimated 11.1 million adult and adolescent vaccines were missed in 2021.
- Pharmacies administered 14.9% less flu vaccines in 2022 compared to 2021.
- In 2021, Pfizer sold $36 billion in vaccines breaking the 2015 record of $6.2 billion.